JPRN-jRCT2080221888未知1 期
A Phase I study of ONO-7268MX1 in patients with hepatocellular carcinoma
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 18 人开始时间: 2012年8月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Patients who have the history of histologically, cytologically or clinically confirmed hepatocellular carcinoma
- •2. Advanced hepatocellular carcinoma patients with no standard or adequate therapeutic options
- •3. Life expectancy of at least 3 months
排除标准
- •1. Patients with severe concomitant desease
- •2. Patients with multiple primary cancers
研究者
相似试验
未知
1 期
Phase I study of ONO-7268MX2Hepatocellular carcinomaJPRN-jRCT2080222427ONO PHARMACEUTICAL CO.,LTD.12
未知
1 期
Phase 1 study of ONO-7056Solid tumorJPRN-jRCT2080221709ONO PHARMACEUTICAL CO.,LTD.36
招募中
1 期
Phase I study of RO7187797 in patients with Multiple myeloma.Multiple myelomaJPRN-jRCT2061220045anki Toshihiro6
进行中（未招募）
1 期
A phase II study of CP-751,871 in patients with recurrent and/or metastatic squamous head and neck carcinoma - IGF-1R protocolEUCTR2008-004707-59-FRCliniques Universitaires Saint Luc-Centre du Cancer
进行中（未招募）
不适用
A phase II study of CP-751,871 in patients with recurrent and/or metastatic squamous head and neck carcinoma - IGF-1R protocolEUCTR2008-004707-59-BECliniques Universitaires Saint Luc-Centre du Cancer37